1-20 of 25
Curtis L. Triplitt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1550-P: Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)

RALPH A. DEFRONZO, GOZDE BASKOY, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, CAROLINA SOLIS-HERRERA, JOHN M. ADAMS, II, ANDREA A. HANSIS-DIARTE, AMALIA GASTALDELLI, ALBERTO CHAVEZ
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1550-P
https://doi.org/10.2337/db24-1550-P
Published: 14 June 2024
View articletitled, 1550-P: Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)
Meeting Abstracts

1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)

GOZDE BASKOY, RICHARD M. PETERSON, JASON W. KEMPENICH, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, MARK S. ANDREW, AURORA MEROVCI, OLGA LAVRYNENKO, ANDREA A. HANSIS-DIARTE, CAROLINA SOLIS-HERRERA, ALBERTO CHAVEZ, MARZIEH SALEHI, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1667-P
https://doi.org/10.2337/db24-1667-P
Published: 14 June 2024
View articletitled, 1667-P: Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)
Meeting Abstracts

910-P: Novel Mechanism of Action Associated with SGLT2 Inhibition, Peripheral Energy Utilization, and CV Benefits in Subjects with Type 2 Diabetes Mellitus and HFrEF

YUEJUAN QIN, NOAH D. SANCHEZ, FRANCISCA M. ACOSTA, ALEXANDER MOODY, SIVARAM NEPPALA, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, RALPH A. DEFRONZO, CAROLINA SOLIS-HERRERA
Journal: Diabetes
Diabetes 2024;73(Supplement_1):910-P
https://doi.org/10.2337/db24-910-P
Published: 14 June 2024
View articletitled, 910-P: Novel Mechanism of Action Associated with SGLT2 Inhibition, Peripheral Energy Utilization, and CV Benefits in Subjects with Type 2 Diabetes Mellitus and HFrEF
Meeting Abstracts

68-LB: Early Pharmacological Intervention (EPIC) to Preserve Beta-Cell Function in Prediabetes (PreDM)

ALBERTO CHAVEZ, AURORA MEROVCI, SIVARAM NEPPALA, LUIS A. CRUZ MORENO, GOZDE BASKOY, FRANCISCA M. ACOSTA, ANDREA A. HANSIS-DIARTE, CURTISS L. PUCKETT, JR., JOHN M. ADAMS, III, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2023;72(Supplement_1):68-LB
https://doi.org/10.2337/db23-68-LB
Published: 20 June 2023
View articletitled, 68-LB: Early Pharmacological Intervention (EPIC) to Preserve Beta-Cell Function in Prediabetes (PreDM)
Meeting Abstracts

124-OR: Effects of Dapagliflozin Therapy on Renal Hemodynamics in Type 2 Diabetes Patients

YUEJUAN QIN, GOZDE BASKOY, CURTIS L. TRIPLITT, CAROLINA SOLIS-HERRERA, JOHN M. ADAMS__III, RALPH A. DEFRONZO, EUGENIO CERSOSIMO
Journal: Diabetes
Diabetes 2023;72(Supplement_1):124-OR
https://doi.org/10.2337/db23-124-OR
Published: 20 June 2023
View articletitled, 124-OR: Effects of Dapagliflozin Therapy on Renal Hemodynamics in Type 2 Diabetes Patients
Meeting Abstracts

99-LB: Myocardial Blood Flow in Association with Baseline Ejection Fraction after Elevation in Plasma Ketones in Patients with T2DM and Heart Failure

CAROLINA SOLIS-HERRERA, YUEJUAN QIN, HENRI HONKA, FRANCISCA M. ACOSTA, ALEXANDER MOODY, ALBERTO CHAVEZ, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2023;72(Supplement_1):99-LB
https://doi.org/10.2337/db23-99-LB
Published: 20 June 2023
View articletitled, 99-LB: Myocardial Blood Flow in Association with Baseline Ejection Fraction after Elevation in Plasma Ketones in Patients with T2DM and Heart Failure
Meeting Abstracts

887-P: Renal Benefit of Dapagliflozin Therapy in Hyperfiltering Type 2 Diabetes Patients

GOZDE BASKOY, YUEJUAN QIN, EUGENIO CERSOSIMO, CAROLINA SOLIS-HERRERA, JOHN M. ADAMS, III, RALPH A. DEFRONZO, CURTIS L. TRIPLITT
Journal: Diabetes
Diabetes 2023;72(Supplement_1):887-P
https://doi.org/10.2337/db23-887-P
Published: 20 June 2023
View articletitled, 887-P: Renal Benefit of Dapagliflozin Therapy in Hyperfiltering Type 2 Diabetes Patients
Meeting Abstracts

98-LB: Effects of SGLT2 Inhibition on Skeletal Muscle Bioenergetics and Myocellular Lipids in Patients with T2D and HFrEF

YUEJUAN QIN, NOAH D. SANCHEZ, ALEXANDER MOODY, FRANCISCA M. ACOSTA, SIVARAM NEPPALA, MARISSA BROWN, HENRI HONKA, LUIS A. CRUZ MORENO, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, RALPH A. DEFRONZO, CAROLINA SOLIS-HERRERA
Journal: Diabetes
Diabetes 2023;72(Supplement_1):98-LB
https://doi.org/10.2337/db23-98-LB
Published: 20 June 2023
View articletitled, 98-LB: Effects of SGLT2 Inhibition on Skeletal Muscle Bioenergetics and Myocellular Lipids in Patients with T2D and HFrEF
Meeting Abstracts

97-LB: Empagliflozin Improves Cardiopulmonary Function and VE/VCO2 in Patients with T2D and HFrEF

YUEJUAN QIN, FRANCISCA M. ACOSTA, SIVARAM NEPPALA, TIFFANY M. CORTES, ALLISON STEPANENKO, ALEXANDER MOODY, NOAH D. SANCHEZ, MARISSA BROWN, LUIS A. CRUZ MORENO, CURTIS L. TRIPLITT, GEOFFREY D. CLARKE, EUGENIO CERSOSIMO, SARA E. ESPINOZA, RALPH A. DEFRONZO, CAROLINA SOLIS-HERRERA
Journal: Diabetes
Diabetes 2023;72(Supplement_1):97-LB
https://doi.org/10.2337/db23-97-LB
Published: 20 June 2023
View articletitled, 97-LB: Empagliflozin Improves Cardiopulmonary Function and VE/VCO2 in Patients with T2D and HFrEF
Journal Articles

A Special Thanks to Lyn Reynolds, Director of the ADA Editorial Office, as She Embarks on Her Retirement

Matthew C. Riddle, MD, David A. D’Alessio, MD, Stephen A. Brunton, MD, Curtis L. Triplitt, PharmD, CDCES
Journal: Diabetes
Diabetes 2022;71(8):1601–1602
https://doi.org/10.2337/db22-en08
Published: 21 August 2022
View articletitled, A Special Thanks to Lyn Reynolds, Director of the ADA Editorial Office, as She Embarks on Her Retirement
Open the PDF for A Special Thanks to Lyn Reynolds, Director of the ADA Editorial Office, as She Embarks on Her Retirement in another window
Meeting Abstracts

175-OR: Effect of Hyperketonemia on Cardiac Efficiency in Patients with Heart Failure and Type 2 Diabetes

CAROLINA SOLIS-HERRERA, YUEJUAN QIN, HENRI HONKA, ALEXANDER MOODY, GEOFFREY D. CLARKE, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2022;71(Supplement_1):175-OR
https://doi.org/10.2337/db22-175-OR
Published: 01 June 2022
View articletitled, 175-OR: Effect of Hyperketonemia on Cardiac Efficiency in Patients with Heart Failure and Type 2 Diabetes
Meeting Abstracts

857-P: Mechanisms of Dapagliflozin to Reduce Intraglomerular Pressure in Patients with Type 2 Diabetes

MARYAM BARKHORDARIAN, CURTIS L. TRIPLITT, CAROLINA SOLIS-HERRERA, JOHN M. ADAMS, III, RALPH A. DEFRONZO, EUGENIO CERSOSIMO
Journal: Diabetes
Diabetes 2022;71(Supplement_1):857-P
https://doi.org/10.2337/db22-857-P
Published: 01 June 2022
View articletitled, 857-P: Mechanisms of Dapagliflozin to Reduce Intraglomerular Pressure in Patients with Type 2 Diabetes
Meeting Abstracts

644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

ALBERTO O. CHAVEZ VELAZQUEZ, EMAD ALI, AURORA MEROVCI, CHRISTINA AGYIN, IV, TOMOKO TERASAWA, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2022;71(Supplement_1):644-P
https://doi.org/10.2337/db22-644-P
Published: 01 June 2022
View articletitled, 644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)
Meeting Abstracts

756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects

MICHAEL EZROKHI, ANTHONY H. CINCOTTA, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, IV, CURTIS L. TRIPLITT, NICHOLAS COMINOS, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2021;70(Supplement_1):756-P
https://doi.org/10.2337/db21-756-P
Published: 01 June 2021
View articletitled, 756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects
Meeting Abstracts

352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study

MARIAM ALATRACH, CHRISTINA AGYIN, IV, JOHN M. ADAMS, II, OLGA LAVRYNENKO, NITCHAKARN LAICHUTHAI, EUGENIO CERSOSIMO, CURTIS L. TRIPLITT, AMALIA GASTALDELLI, MUHAMMAD ABDUL-GHANI, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2020;69(Supplement_1):352-OR
https://doi.org/10.2337/db20-352-OR
Published: 01 June 2020
View articletitled, 352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study
Meeting Abstracts

1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

MARIAM ALATRACH, CHRISTINA AGYIN, IV, NITCHAKARN LAICHUTHAI, OLGA LAVRYNENKO, JOHN M. ADAMS, II, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1136-P
https://doi.org/10.2337/db20-1136-P
Published: 01 June 2020
View articletitled, 1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes
Meeting Abstracts

1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects

MICHAEL EZROKHI, ANTHONY CINCOTTA, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, IV, CURTIS L. TRIPLITT, NICHOLAS COMINOS, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1070-P
https://doi.org/10.2337/db20-1070-P
Published: 01 June 2020
View articletitled, 1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects
Meeting Abstracts

246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients

MARIAM ALATRACH, CHRISTINA AGYIN, IV, NITCHAKARN LAICHUTHAI, JOHN M. ADAMS, II, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO
Journal: Diabetes
Diabetes 2019;68(Supplement_1):246-OR
https://doi.org/10.2337/db19-246-OR
Published: 01 June 2019
View articletitled, 246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients
Meeting Abstracts

1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

BINDU CHAMARTHI, EUGENIO CERSOSIMO, JOHN M. ADAMS, II, MARIAM ALATRACH, CHRISTINA AGYIN, CURTIS L. TRIPLITT, MICHAEL EZROKHI, SHUQIN LUO, EMILIE DUVALLET, ANTHONY H. CINCOTTA, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1166-P
https://doi.org/10.2337/db19-1166-P
Published: 01 June 2019
View articletitled, 1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)
Meeting Abstracts

155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion

CAROLINA SOLIS-HERRERA, MARIAM ALATRACH, CHRISTINA AGYIN, HENRI HONKA, RUPAL PATEL, CURTIS L. TRIPLITT, JOHN M. ADAMS, II, AMALIA GASTALDELLI, MUHAMMAD ABDUL-GHANI, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Journal: Diabetes
Diabetes 2019;68(Supplement_1):155-LB
https://doi.org/10.2337/db19-155-LB
Published: 01 June 2019
View articletitled, 155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion